Annual Total Liabilities
$1.36 B
-$3.25 M-0.24%
31 December 2022
Summary:
NuVasive annual total liabilities is currently $1.36 billion, with the most recent change of -$3.25 million (-0.24%) on 31 December 2022. During the last 3 years, it has fallen by -$3.25 million (-0.24%).NUVA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$1.20 B
-$96.47 M-7.46%
30 June 2023
Summary:
NuVasive quarterly total liabilities is currently $1.20 billion, with the most recent change of -$96.47 million (-7.46%) on 30 June 2023.NUVA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVA Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -0.2% | -11.9% |
| 5 y5 years | +39.7% | +23.4% |
NUVA Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -23.6% | -32.5% |
NuVasive Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $1.20 B(-7.5%) |
| Mar 2023 | - | $1.29 B(-4.6%) |
| Dec 2022 | $1.36 B(-0.2%) | $1.36 B(+1.0%) |
| Sept 2022 | - | $1.34 B(-0.4%) |
| June 2022 | - | $1.35 B(-0.1%) |
| Mar 2022 | - | $1.35 B(-0.8%) |
| Dec 2021 | $1.36 B(-23.4%) | $1.36 B(+3.7%) |
| Sept 2021 | - | $1.31 B(+0.3%) |
| June 2021 | - | $1.31 B(-1.8%) |
| Mar 2021 | - | $1.33 B(-25.1%) |
| Dec 2020 | $1.77 B(+82.9%) | $1.77 B(+1.0%) |
| Sept 2020 | - | $1.76 B(+0.1%) |
| June 2020 | - | $1.76 B(+31.5%) |
| Mar 2020 | - | $1.33 B(+37.5%) |
| Dec 2019 | $970.08 M(+11.1%) | $970.08 M(+0.7%) |
| Sept 2019 | - | $963.24 M(+2.2%) |
| June 2019 | - | $942.59 M(+3.5%) |
| Mar 2019 | - | $911.10 M(+4.3%) |
| Dec 2018 | $873.33 M(+3.9%) | $873.33 M(+0.2%) |
| Sept 2018 | - | $871.78 M(-2.2%) |
| June 2018 | - | $891.17 M(-1.9%) |
| Mar 2018 | - | $908.74 M(+8.1%) |
| Dec 2017 | $840.72 M(-3.4%) | $840.72 M(-3.2%) |
| Sept 2017 | - | $868.72 M(-1.6%) |
| June 2017 | - | $882.78 M(+1.3%) |
| Mar 2017 | - | $871.41 M(+0.1%) |
| Dec 2016 | $870.28 M(+49.1%) | $870.28 M(-4.7%) |
| Sept 2016 | - | $913.23 M(+1.7%) |
| June 2016 | - | $898.05 M(-2.1%) |
| Mar 2016 | - | $917.43 M(+57.1%) |
| Dec 2015 | $583.82 M(-15.8%) | $583.82 M(+0.6%) |
| Sept 2015 | - | $580.27 M(-4.9%) |
| June 2015 | - | $610.40 M(-3.4%) |
| Mar 2015 | - | $632.13 M(-8.8%) |
| Dec 2014 | $693.21 M(+20.6%) | $693.21 M(+8.8%) |
| Sept 2014 | - | $636.97 M(+1.8%) |
| June 2014 | - | $625.81 M(+0.8%) |
| Mar 2014 | - | $620.60 M(+8.0%) |
| Dec 2013 | $574.69 M | $574.69 M(+2.2%) |
| Sept 2013 | - | $562.12 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | - | $551.00 M(-1.3%) |
| Mar 2013 | - | $558.03 M(-10.9%) |
| Dec 2012 | $626.21 M(-0.5%) | $626.21 M(-2.6%) |
| Sept 2012 | - | $642.83 M(+1.4%) |
| June 2012 | - | $634.24 M(+0.8%) |
| Mar 2012 | - | $629.09 M(-0.1%) |
| Dec 2011 | $629.52 M(+76.9%) | $629.52 M(-3.1%) |
| Sept 2011 | - | $649.64 M(-13.5%) |
| June 2011 | - | $750.71 M(+114.8%) |
| Mar 2011 | - | $349.45 M(-1.8%) |
| Dec 2010 | $355.80 M(+3.7%) | $355.80 M(+1.6%) |
| Sept 2010 | - | $350.35 M(+2.3%) |
| June 2010 | - | $342.60 M(+0.1%) |
| Mar 2010 | - | $342.19 M(-0.2%) |
| Dec 2009 | $342.97 M(+14.4%) | $342.97 M(-2.2%) |
| Sept 2009 | - | $350.78 M(+2.4%) |
| June 2009 | - | $342.41 M(+7.0%) |
| Mar 2009 | - | $319.88 M(+6.7%) |
| Dec 2008 | $299.77 M(+929.8%) | $299.77 M(+2.1%) |
| Sept 2008 | - | $293.47 M(+11.4%) |
| June 2008 | - | $263.49 M(-0.7%) |
| Mar 2008 | - | $265.29 M(+811.4%) |
| Dec 2007 | $29.11 M(+46.4%) | $29.11 M(+18.6%) |
| Sept 2007 | - | $24.55 M(+15.3%) |
| June 2007 | - | $21.29 M(+4.1%) |
| Mar 2007 | - | $20.45 M(+2.8%) |
| Dec 2006 | $19.88 M(+48.9%) | $19.88 M(+1.4%) |
| Sept 2006 | - | $19.60 M(-25.8%) |
| June 2006 | - | $26.43 M(+91.4%) |
| Mar 2006 | - | $13.81 M(+3.4%) |
| Dec 2005 | $13.35 M(+42.7%) | $13.35 M(-0.4%) |
| Sept 2005 | - | $13.40 M(-1.1%) |
| June 2005 | - | $13.55 M(+24.4%) |
| Mar 2005 | - | $10.90 M(+16.5%) |
| Dec 2004 | $9.36 M(-23.9%) | $9.36 M(+18.9%) |
| Sept 2004 | - | $7.87 M(+6.9%) |
| June 2004 | - | $7.36 M(-39.7%) |
| Mar 2004 | - | $12.20 M |
| Dec 2003 | $12.30 M(+121.7%) | - |
| Dec 2002 | $5.55 M(+3.1%) | - |
| Dec 2000 | $5.38 M | - |
FAQ
- What is NuVasive annual total liabilities?
- What is the all time high annual total liabilities for NuVasive?
- What is NuVasive quarterly total liabilities?
- What is the all time high quarterly total liabilities for NuVasive?
What is NuVasive annual total liabilities?
The current annual total liabilities of NUVA is $1.36 B
What is the all time high annual total liabilities for NuVasive?
NuVasive all-time high annual total liabilities is $1.77 B
What is NuVasive quarterly total liabilities?
The current quarterly total liabilities of NUVA is $1.20 B
What is the all time high quarterly total liabilities for NuVasive?
NuVasive all-time high quarterly total liabilities is $1.77 B